Fifteen patients (nine COPD, six non-COPD) were randomly assigned to receive either volume-limited or pressure-limited NPPV and were switched to the complementary mode after 6 weeks.
Ten patients (five COPD, five non-COPD) completed the study. PaCO2 during sleep comparably decreased from 54.6±8.0 to 46.2±6.1 mmHg during volume-limited NPPV (P<0.05), and to 46.5±6.4 mmHg during pressure-limited NPPV (P<0.05). Improvements in sleep quality assessed by polysomnography were comparable, but less gastrointestinal side effects were reported for pressure-limited NPPV (P<0.05). Using a pneumotachograph the variance of inspiratory volumes was lower, but the variance of peak inspiratory pressures was higher during volume-limited NPPV compared to pressure-limited NPPV. Substantial leak volumes which accounted for 57 % (volume-limited NPPV) and for 58 % (pressure-limited NPPV) of the applied inspiratory volume were independent from the mode of ventilation.
In conclusion, nocturnal volume- and pressure-limited NPPV have similar effects on gas exchange and sleep quality in patients with hypercapnic chronic respiratory failure, but volume-limited NPPV is associated with more gastrointestinal side effects.